- All
- Blog
- Grants
- News
- Newsletter
- Press Release
- Publications
- Uncategorized
- Webinar
Working at Toxys as a BD & Sales Manager
[vc_row css=".vc_custom_1727793192295{padding-top: 2% !important;padding-right: 2% !important;padding-bottom: 2% !important;padding-left: 2% !important;}"][vc_column width="1/4"][vc_single_image image="15449" img_size="full" alignment="center"][/vc_column][vc_column width="3/4"][vc_column_text]Name: Katarina Spencer Role: Business Development and Sales Manager With Toxys since: 2024 Background: Genetics From: South Africa[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text] Can you give us a brief description of your role at Toxys? My overarching role is to act as...
New Book Chapter: Genetic Toxicology Testing in Comprehensive Toxicology
[vc_row][vc_column width="1/6"][vc_single_image image="15845" img_size="full"][/vc_column][vc_column width="5/6"][vc_column_text]Present day genetic toxicity testing looks different than it did 20 years ago. The chapter dedicated to this topic in Comprehensive Toxicology has been revised with a focus on genotoxic mechanisms. In addition to identifying mutagenicity, aneugenicity, and clastogenicity, new approach...
Press Release: Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing
[vc_row][vc_column][vc_empty_space height="50px"][/vc_column][/vc_row][vc_row][vc_column width="2/3"][vc_column_text] PRESS RELEASE [/vc_column_text][/vc_column][vc_column width="1/6"][vc_single_image image="15778" img_size="full"][/vc_column][vc_column width="1/6"][vc_single_image image="15779" img_size="full"][/vc_column][/vc_row][vc_row][vc_column][vc_column_text] Charles River and Toxys Announce Collaboration to Validate the Use of NAMs for Developmental Toxicity Testing WILMINGTON, Mass. – October 8, 2025 – Charles River Laboratories International, Inc. (NYSE: CRL) and Toxys today announced a collaboration to...
New publication: Trilineage differentiation in ReproTracker for accurate teratogenicity assessment
Toxys scientists recently published an article in Frontiers in Toxicology entitled “Implementing a trilineage differentiation in the ReproTracker assay for improved teratogenicity assessment”. This publication not only describes the optimization of ReproTracker to include assessment of neurodevelopmental toxicants and in a higher throughput manner, but...
NAMs for Assessing Developmental Toxicity of Pharmaceuticals: Moving the Needle Forward
Scientist from various prestigious organizations, including Toxys CSO Amer Jamalpoor, recently published “New approach methodologies for assessing developmental toxicity of pharmaceuticals: Case examples and future directions” in Reproductive Toxicology. Below, we share highlights from this publication, which can be accessed here. This manuscript is part of...
New Publication: Cellular uptake and genotoxic potential of industrial relevant nanomaterials in vitro
Evaluating the potential genotoxicity of nanomaterials (NMs) presents a unique challenge when using cell-based models. In addition to the requirement for physicochemical characterization of the test article, a negative genotoxicity test result is only trusted if the material has access to internal cellular components (evidence...
Press Release: ToxTracker® Approved by OECD for Incorporation into Test Guideline Programme
[vc_row][vc_column][vc_empty_space height="50px"][vc_column_text] PRESS RELEASE ToxTracker® Approved by OECD for Incorporation into Test Guideline Programme Oegstgeest, The Netherlands. September 4th, 2025 - Toxys, a leading innovator in animal-free toxicology solutions, announces that its flagship product, ToxTracker®, has been accepted into the Organization for Economic Co-operation and Development (OECD) Test Guidelines Programme....
ToxTracker EMP launches as a service for evaluating the genotoxic potential of N-nitrosamines
[vc_row][vc_column][vc_column_text]ToxTracker EMP (enhanced metabolization protocol) is a modified ToxTracker protocol to investigate the genotoxic potential of N-nitrosamines (NAs) in the presence of exogeneous metabolism. This enhanced protocol, which may be used across mammalian cell systems, greatly improves bioactivation of NAs and increases the sensitivity of...
Working at Toxys as a Study Investigator
[vc_row css=".vc_custom_1727793192295{padding-top: 2% !important;padding-right: 2% !important;padding-bottom: 2% !important;padding-left: 2% !important;}"][vc_column width="1/4"][vc_single_image image="15444" img_size="full" alignment="center"][/vc_column][vc_column width="3/4"][vc_column_text]Name: Eva de Tombe Role: Study investigator in investigative toxicology team With Toxys since: 2023 Background: Bio-Pharmaceutical Sciences From: The Netherlands[/vc_column_text][/vc_column][/vc_row][vc_row][vc_column][vc_column_text] Can you give us a brief description of your role at Toxys? I am responsible for...
A tiered approach to developmental and reproductive toxicology with NAMs
[vc_row][vc_column][vc_column_text]Unilever and Toxys scientists recently published an article in Frontiers in Toxicology entitled “An advancement in developmental and reproductive toxicity (DART) risk assessment: evaluation of a bioactivity and exposure-based NAM toolbox”. The DART NAM toolbox and NGRA framework As outlined in Next Generation Risk Assessment (NGRA) frameworks,...
